Heart implant tested to ease strain in severe lung pressure disease

NCT ID NCT03022851

Completed Disease control Sponsor: Occlutech International AB Source: ClinicalTrials.gov ↗

Summary

This study tested a small device implanted in the heart to help control severe pulmonary hypertension, a condition of dangerously high blood pressure in the lungs. It involved 32 patients who had run out of other treatment options. The main goal was to see if the device was safe and if it could reduce fainting spells and improve symptoms.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

Ankara Etlik Şehir Hastanesi

Ankara, Yenimahalle, 06170, Turkey (Türkiye)
Ege Üniversitesi Tıp Fakültesi Hastanesi

Izmir, Bornova, 35100, Turkey (Türkiye)
Gdański Uniwersytet Medyczny

Gdansk, 80-952, Poland
Hacettepe Üniversitesi Tıp Fakültesi

Ankara, Altındağ, 06230, Turkey (Türkiye)
Justus-Liebig Universität

Giesen, 35385, Germany
Klinikum der Universität München

Munich, Bavaria, 81377, Germany
Kocaeli Üniversitesi Araştırma ve Uygulama Hastanesi

Kocaeli, Turkey (Türkiye)
Sağlık Bilimleri Üniversitesi Tepecik Eğitim ve Araştırma Hastanesi

Izmir, Konak, 35020, Turkey (Türkiye)
Szpital Kliniczny Przemienienia Pańskiego Uniwersytetu Medycznego

Poznan, 61-848, Poland
Szpital im. Fryderyka Chopina

Otwock, 05-400, Poland
Universitätsklinikum Würzburg

Würzburg, 97080, Germany
Uniwersytet Jagielloński Collegium Medicum

Krakow, 31-202, Poland

Conditions

Explore the condition pages connected to this study.

PULMONARY HYPERTENSION